Thomas Brüning Selected Research

Carcinogenesis

1/2018	Influence of quartz exposure on lung cancer types in cases of lymph node-only silicosis and lung silicosis in German uranium miners.
1/2012	Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen.
5/2011	No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk.
12/2010	The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors.
7/2008	Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.
3/2008	Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.
7/2002	Nephrotoxicity and nephrocarcinogenicity of dinitrotoluene: new aspects to be considered.
6/2002	Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Brüning Research Topics

Disease

76	Neoplasms (Cancer) 05/2024 - 07/2002
56	Breast Neoplasms (Breast Cancer) 10/2023 - 12/2004
29	Lung Neoplasms (Lung Cancer) 01/2024 - 07/2009
21	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 02/2002
20	Malignant Mesothelioma 12/2022 - 01/2007
17	Mesothelioma 04/2024 - 01/2007
11	Inflammation (Inflammations) 06/2022 - 02/2010
10	AIDS-Related Complex (ARC) 01/2022 - 01/2012
10	Hypersensitivity (Allergy) 06/2021 - 09/2002
10	Asthma (Bronchial Asthma) 10/2017 - 05/2005
9	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2011
8	Carcinogenesis 01/2018 - 06/2002
7	Renal Cell Carcinoma (Grawitz Tumor) 11/2007 - 02/2002
5	Kidney Neoplasms (Kidney Cancer) 04/2014 - 04/2004
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 01/2012
4	Adenocarcinoma 01/2024 - 07/2009
4	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022 - 06/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 07/2009
4	Occupational Asthma 01/2019 - 01/2015
3	Disease Progression 04/2024 - 01/2016
3	Triple Negative Breast Neoplasms 01/2023 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2013
3	Body Weight (Weight, Body) 01/2021 - 05/2013
3	Fever (Fevers) 01/2021 - 12/2018
3	Carcinoma (Carcinomatosis) 09/2019 - 12/2017
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2012
3	Silicosis 01/2018 - 07/2009
3	Familial Breast Cancer 11/2017 - 03/2008
3	Cough 09/2015 - 01/2013
2	Contact Dermatitis (Eczema, Contact) 05/2023 - 10/2012
2	Cognitive Dysfunction 01/2023 - 08/2015
2	Adenocarcinoma of Lung 01/2021 - 12/2013
2	Asbestosis 01/2021 - 01/2010
2	Hypertension (High Blood Pressure) 01/2021 - 10/2017
2	Genetic Risk Score 01/2020 - 05/2015

Drug/Important Bio-Agent (IBA)

39	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2004
25	Estrogen ReceptorsIBA 03/2022 - 09/2008
23	Proteins (Proteins, Gene)FDA Link 06/2023 - 10/2006
21	AsbestosIBA 05/2024 - 01/2010
15	CarcinogensIBA 01/2024 - 07/2002
15	MetalsIBA 01/2023 - 01/2012
15	Hormones (Hormone)IBA 01/2022 - 10/2006
12	EnzymesIBA 08/2015 - 02/2002
10	Calbindin 2IBA 04/2024 - 05/2010
10	MesothelinIBA 12/2022 - 01/2007
9	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2004
8	ORALIT (ORS)IBA 01/2023 - 03/2008
8	AminesIBA 01/2016 - 06/2003
7	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2024 - 06/2005
7	Progesterone Receptors (Progesterone Receptor)IBA 03/2022 - 03/2010
7	Tumor Biomarkers (Tumor Markers)IBA 12/2020 - 01/2007
7	Peptides (Polypeptides)IBA 01/2017 - 01/2006
6	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2011
6	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2023 - 10/2011
6	MicroRNAs (MicroRNA)IBA 02/2019 - 01/2012
6	AllergensIBA 01/2018 - 01/2012
6	Immunoglobulin E (IgE)IBA 06/2015 - 09/2002
5	SurvivinIBA 01/2022 - 06/2010
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2021 - 01/2015
5	UraniumIBA 11/2018 - 07/2009
5	LatexIBA 01/2012 - 04/2002
5	Trichloroethylene (Trichloroethene)IBA 11/2007 - 03/2003
4	chromium hexavalent ionIBA 01/2024 - 12/2018
4	AntibodiesIBA 01/2023 - 01/2006
4	human ERBB2 proteinIBA 01/2022 - 05/2009
4	SmokeIBA 02/2014 - 06/2002
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2024 - 01/2020
3	NickelIBA 01/2024 - 11/2019
3	Irritants (Vesicants)IBA 05/2023 - 10/2012
3	Messenger RNA (mRNA)IBA 10/2020 - 06/2010
3	Zinc Oxide FDA Link 01/2020 - 12/2018
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2015
3	IronIBA 01/2019 - 05/2005
3	QuartzIBA 01/2018 - 07/2009
3	Codon (Codons)IBA 02/2016 - 06/2002
3	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2016 - 06/2003
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2016 - 06/2002
3	3' Untranslated Regions (3' UTR)IBA 01/2016 - 01/2014
3	2,6-dinitrotoluene (DNT)IBA 04/2014 - 07/2002
3	DinitrobenzenesIBA 04/2014 - 09/2005
3	CopperIBA 04/2014 - 07/2002
3	Estrogens (Estrogen)FDA Link 04/2013 - 07/2008
3	XenobioticsIBA 10/2006 - 02/2002
2	MelatoninIBA 10/2023 - 12/2014
2	Benzo(a)pyreneIBA 06/2023 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2014
2	AntigensIBA 01/2023 - 12/2020
2	CreatinineIBA 01/2022 - 11/2013
2	mahuang-tangIBA 01/2022 - 12/2013
2	Cysteine-Rich Protein 61IBA 11/2021 - 01/2021
2	PlatinumIBA 06/2021 - 01/2017
2	SaltsIBA 06/2021 - 01/2017
2	IsotopesIBA 01/2021 - 03/2020
2	Phenobarbital (Luminal)FDA Link 10/2020 - 01/2020
2	TungstenIBA 10/2020 - 12/2018

Therapy/Procedure

10	Therapeutics 12/2023 - 05/2009
7	Lasers (Laser) 01/2017 - 12/2004
3	Drug Therapy (Chemotherapy) 01/2021 - 02/2009
3	Hormone Replacement Therapy (Therapy, Hormone Replacement) 12/2013 - 01/2005
2	Adjuvant Chemotherapy 04/2024 - 10/2020